Received: 26 February 2019
Accepted: 26 April 2019
First Online: 16 May 2019
Ethics approval and consent to participate
: WSvH reports no conflict of interest. AMvdB received research grants, consultation fees and/or travel support from Amgen/Novartis, Eli Lilly/CoLucid, Teva and ATI.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.